Pathological gambling caused by drugs used to treat Parkinson disease.
about
Gambling disorder during dopamine replacement treatment in Parkinson's disease: a comprehensive reviewThe neurobiology and genetics of impulse control disorders: relationships to drug addictionsFrequency of new-onset pathologic compulsive gambling or hypersexuality after drug treatment of idiopathic Parkinson diseaseGambling addiction: insights from neuroscience and neuroimagingAddiction and the brain-disease fallacyNonhuman gamblers: lessons from rodents, primates, and robotsParkinson disease drug screening based on the interaction between D(2) dopamine receptor and beta-arrestin 2 detected by capillary zone electrophoresisDopamine agonists and the suppression of impulsive motor actions in Parkinson disease.The risky business of dopamine agonists in Parkinson disease and impulse control disorders.Risk-taking and pathological gambling behavior in Huntington's diseaseGambling severity predicts midbrain response to near-miss outcomes.Dopamine agonist increases risk taking but blunts reward-related brain activity.Risk Taking for Potential Reward Decreases across the Lifespan.Reward networks in the brain as captured by connectivity measuresImpulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control studyDopamine, reward, and frontostriatal circuitry in impulse control disorders in Parkinson's disease: insights from functional imaging.Decision-making during gambling: an integration of cognitive and psychobiological approaches.The role of dopamine in risk taking: a specific look at Parkinson's disease and gamblingThe roles of dopamine and serotonin in decision making: evidence from pharmacological experiments in humansValidation of the questionnaire for impulsive-compulsive disorders in Parkinson's disease.Amantadine use associated with impulse control disorders in Parkinson disease in cross-sectional study.Characterization of the dopamine receptor system in adult rhesus monkeys exposed to cocaine throughout gestation.Detecting associations between behavioral addictions and dopamine agonists in the Food & Drug Administration's Adverse Event database.Hold your horses: impulsivity, deep brain stimulation, and medication in parkinsonism.Modulation of habit formation by levodopa in Parkinson's disease.Gabapentin enacarbil (XP13512/GSK1838262) as an alternative treatment to dopaminergic agents for restless legs syndrome.Pramipexole-induced disruption of behavioral processes fundamental to intertemporal choice.Sensitivity and bias in decision-making under risk: evaluating the perception of reward, its probability and valueLoosening addiction's deadly grip. Recent research paints a picture of addiction as a progressive, chronic neurological disease that wreaks havoc with brain chemistry.Maladaptive reward-learning and impulse control disorders in patients with Parkinson's disease: a clinical overview and pathophysiology updateBehavioral effects of levodopa.Seniors with Parkinson's disease: initial medical treatment.Criteria for deep-brain stimulation in Parkinson's disease: review and analysis.Pramipexole and compulsive masturbationNeural signature of fictive learning signals in a sequential investment task.Pathological Gambling Associated With Aripiprazole or Dopamine Replacement Therapy: Do Patients Share the Same Features? A Review.Risky business: the neuroeconomics of decision making under uncertaintyGlycyrrhetinic acid and E.resveratroloside act as potential plant derived compounds against dopamine receptor D3 for Parkinson's disease: a pharmacoinformatics study.Patient versus informant reporting of ICD symptoms in Parkinson's disease using the QUIP: validity and variabilityImpulsive behavior and associated clinical variables in Parkinson's disease.
P2860
Q21284663-900DF2FC-4353-407C-BC06-033E51B1CDCBQ24642641-87BC9606-69BD-469D-8E4D-75418BE9BDABQ24646422-896F3250-970D-4D81-A386-5C38F16690F6Q26784118-0FC95A50-B13B-427B-8162-CC6C9C9BAC23Q26865252-900F3579-0F1C-45EF-8F52-A263F80C68ECQ26992129-0F9F7462-E76B-4DDC-B592-36CEE3BF8900Q28833697-D82DDBA4-8BC2-4141-93AF-CD872BA304A7Q30419267-F3F4D3ED-1513-4131-B638-A8D7C50BAA8EQ30425695-68BBC7BC-081E-4906-BC9F-E279AC866A9CQ30439699-737D9D99-4165-444F-BF3F-E901CAD9D41BQ30496315-83D25652-2DC2-4855-ABB0-C9B2F775A0F9Q33346213-6835B72E-22A4-4B10-B414-274DF146ECEFQ33449053-42F98391-36F2-4B50-A38D-9087703AF617Q33552301-B222D82C-00DA-4ADB-9CA8-428A75D9C31AQ33573874-6DD8603A-FAA9-4157-BCF1-C5D30EB91225Q33593384-431B03C9-14A1-4677-A2E7-B1BEE6971273Q33683378-BA95637D-27C7-43FE-8E1A-534662122035Q33687660-EAA57583-66D7-45E7-81A0-C1E01313ED1EQ33706269-402806D5-7246-4845-9621-7E79971F5FA0Q33767351-F4E6DC1E-46D3-42EA-B034-31510FC3C196Q33770775-08763CB4-810B-415B-ADA6-E97C501AA767Q33884637-9D1FD098-0A3F-4AAA-AFE7-A224DB4BF83EQ33980856-92CEEBB7-B603-4F79-9825-3975A3BD826FQ34007828-52B97D7C-3F27-4896-9580-FC434573E7A7Q34081731-858CD7F5-827C-48A2-977D-6E8A67278B87Q34125935-26C9B9D6-6872-4A04-8B95-56F1877FCD40Q34165153-1F63D158-80A3-4F3D-B553-6003ED6F2DC8Q34228264-0EF858B1-A762-4993-B97F-F1B40A7CC104Q34360839-9D8FFDD0-DF72-4508-9B13-76E31A609BF2Q34423280-1E7B996B-4442-426B-BB32-8F427760F520Q34452922-99A5F298-8E1F-4C3E-B58D-EA76FF63A29DQ34508143-41423CF1-C745-483B-8202-E1F6CCE5F20EQ34587070-042B2A62-AC32-48D1-9DC3-B4FDAEB6DB5BQ34620342-2D34A302-6392-4B7A-9D11-C8DD8B2C46B4Q34630857-A5E1CA6C-3D19-400F-B671-7C428256C036Q34674778-DC9A8AAC-5983-457B-9D4A-724174E51FFBQ34725684-2C26D8B2-B736-4E4A-8D11-E50AC709BD94Q34770959-56C548AF-2EE1-4F79-9762-5D359EBDAA34Q34774765-ACA91308-E2CE-4521-89D3-7D44C52649B7Q34778024-92A2D4BD-7238-42AB-9239-5C621AE5EA4D
P2860
Pathological gambling caused by drugs used to treat Parkinson disease.
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Pathological gambling caused by drugs used to treat Parkinson disease.
@ast
Pathological gambling caused by drugs used to treat Parkinson disease.
@en
type
label
Pathological gambling caused by drugs used to treat Parkinson disease.
@ast
Pathological gambling caused by drugs used to treat Parkinson disease.
@en
prefLabel
Pathological gambling caused by drugs used to treat Parkinson disease.
@ast
Pathological gambling caused by drugs used to treat Parkinson disease.
@en
P2093
P1433
P1476
Pathological gambling caused by drugs used to treat Parkinson disease.
@en
P2093
James H Bower
Keith A Josephs
Kevin J Klos
M Leann Dodd
Yonas E Geda
P304
P356
10.1001/ARCHNEUR.62.9.NOC50009
P577
2005-07-11T00:00:00Z